If Biomaven predictions hold true, then there isn't a lot of value in Iclusig for CML, even with FDA and EMA nods to move forward. It will probably take until May before we have an answer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.